GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » Aetna Inc (NYSE:AET) » Definitions » Sloan Ratio %

Aetna (AET) Sloan Ratio % : 0.04% (As of Sep. 2018)


View and export this data going back to 1968. Start your Free Trial

What is Aetna Sloan Ratio %?

Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.

Aetna's Sloan Ratio for the quarter that ended in Sep. 2018 was 0.04%.

As of Sep. 2018, Aetna has a Sloan Ratio of 0.04%, indicating the company is in the safe zone and there is no funny business with accruals.


Aetna Sloan Ratio % Historical Data

The historical data trend for Aetna's Sloan Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aetna Sloan Ratio % Chart

Aetna Annual Data
Trend Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17
Sloan Ratio %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.12 1.49 -0.84 -1.54 -0.66

Aetna Quarterly Data
Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18
Sloan Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.24 -0.66 -3.30 -4.58 0.04

Competitive Comparison of Aetna's Sloan Ratio %

For the Healthcare Plans subindustry, Aetna's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aetna's Sloan Ratio % Distribution in the Healthcare Plans Industry

For the Healthcare Plans industry and Healthcare sector, Aetna's Sloan Ratio % distribution charts can be found below:

* The bar in red indicates where Aetna's Sloan Ratio % falls into.



Aetna Sloan Ratio % Calculation

Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.

Aetna's Sloan Ratio for the fiscal year that ended in Dec. 2017 is calculated as

Sloan Ratio=(Net Income (A: Dec. 2017 )-Cash Flow from Operations (A: Dec. 2017 )
-Cash Flow from Investing (A: Dec. 2017 ))/Total Assets (A: Dec. 2017 )
=(1904--464
-2730)/55151
=-0.66%

Aetna's Sloan Ratio for the quarter that ended in Sep. 2018 is calculated as

Sloan Ratio=(Net Income (TTM)-Cash Flow from Operations (TTM))
-Cash Flow from Investing (TTM))/Total Assets (Q: Sep. 2018 )
=(3665-997
-2646)/57103
=0.04%

Aetna's Net Income for the trailing twelve months (TTM) ended in Sep. 2018 was 244 (Dec. 2017 ) + 1209 (Mar. 2018 ) + 1212 (Jun. 2018 ) + 1000 (Sep. 2018 ) = $3,665 Mil.
Aetna's Cash Flow from Operations for the trailing twelve months (TTM) ended in Sep. 2018 was -2688 (Dec. 2017 ) + 3341 (Mar. 2018 ) + 1044 (Jun. 2018 ) + -700 (Sep. 2018 ) = $997 Mil.
Aetna's Cash Flow from Investing for the trailing twelve months (TTM) ended in Sep. 2018 was 2061 (Dec. 2017 ) + 684 (Mar. 2018 ) + -296 (Jun. 2018 ) + 197 (Sep. 2018 ) = $2,646 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aetna  (NYSE:AET) Sloan Ratio % Explanation

A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.

According to How to Beat the Market with the Sloan Ratio:

If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.

If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.

If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.

As of Sep. 2018, Aetna has a Sloan Ratio of 0.04%, indicating the company is in the safe zone and there is no funny business with accruals.


Aetna Sloan Ratio % Related Terms

Thank you for viewing the detailed overview of Aetna's Sloan Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.


Aetna (AET) Business Description

Traded in Other Exchanges
N/A
Address
Aetna is one of the largest managed-care organizations in the U.S., with over 22 million medical members. This large member count helps the firm diversify its operating risk and has formed the basis for material competitive advantages. The firm provides health insurance services to its members through products that encompass every major insurance market--individual, group, and government sponsored. Aetna and CVS recently announced their intention to merge operations, and if approved, it would form one of the most powerful players within the healthcare space.
Executives
Fernando Aguirre director CHIQUITA BRANDS INTERNATIONAL, 250 EAST FIFTH STREET, CINCINNATI OH 45202
Harold L Paz officer: EVP & Chief Medical Officer AETNA INC., 151 FARMINGTON AVENUE, HARTFORD CT 06156
Molly Joel Coye director AETNA INC, 151 FARMINGTON AVENUE, HARTFORD CT 06156
Jeffrey E Garten director AETNA INC., 151 FARMINGTON AVENUE, HARTFORD CT 06156
Frank M Clark director AETNA INC., 151 FARMINGTON AVENUE, HARTFORD CT 06156
Shawn M Guertin officer: Exec. Vice President, CFO TRINET GROUP, INC., ONE PARK PLACE, SUITE 600, DUBLIN CA 94568
Mark T Bertolini director, officer: Chairman and CEO AETNA INC., 151 FARMINGTON AVENUE, HARTFORD CT 06156
Karen S Lynch officer: President 151 FARMINGTON AVENUE, RW61, HARTFORD CT 06156
Roger N Farah director POLO RALPH LAUREN CORP, 650 MADISON AVE, NEW YORK NY 10022
Ellen M Hancock director 126 LIMESTONE ROAD, RIDGEFIELD CT 06877
Edward J Ludwig director C/O BECTON DICKERSON & CO, 1 BECTON DR, FRANKLIN LAKES NJ 07417
Margaret M Mccarthy officer: EVP, Operations & Technology AETNA INC., 151 FARMINGTON AVENUE, HARTFORD CT 06156
Olympia J. Snowe director 100 E. PRATT STREET, BALTIMORE MD 21202
Heather Brianne Dixon officer: VP, Controller & CAO AETNA INC., 151 FARMINGTON AVENUE, HARTFORD CT 06156
Sabatino Thomas J Jr officer: EVP & General Counsel C/O JAN STERN REED BAXTER INTERNATIONAL, ONE BAXTER PARKWAY DF2 2W, DEERFIELD IL 60015

Aetna (AET) Headlines

From GuruFocus

Aetna, Cisco Top Greenblatt Magic Formula Screener

By Sheila Dang Sheila Dang 06-15-2015

George Soros Exits Aetna, Microsoft

By Tiziano Frateschi Tiziano Frateschi 02-22-2019

14 Best Undervalued Stocks of the Week

By Benjamin Clark Benjamin Clark 08-09-2016

Aetna the Undaunted Insurer

By Mark Yu Mark Yu 10-31-2016

Paul Tudor Jones Continues to Buy Apple, Alibaba

By Tiziano Frateschi Tiziano Frateschi 11-29-2018

Huge Long Term Upside Still Available In Aetna Inc.

By Quantified Alpha Quantified Alpha 05-14-2015

The Eaton Vance Fund Exits Aetna, Bristol Myers

By Tiziano Frateschi Tiziano Frateschi 01-31-2019

5 Undervalued Companies With a Low Beta

By Benjamin Clark Benjamin Clark 08-03-2016